<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
	<title>Proactiveinvestors United Kingdom Xenetic Biosciences  RNS press releases</title>
	<link>http://www.proactiveinvestors.co.uk</link>
	<description>Proactiveinvestors United Kingdom Xenetic Biosciences  RNS press releases RSS feed
            </description>
	<language>en</language>
	<pubDate>Thu, 24 May 2012 15:06:58 +0100</pubDate>
	<docs>http://blogs.law.harvard.edu/tech/rss</docs>
	<generator>Genera CMS</generator>
	<managingEditor>action@proactiveinvestors.com (Proactiveinvestors)</managingEditor>
	<webMaster>action@proactiveinvestors.com (Proactiveinvestors)</webMaster>
	<atom:link href="http://www.proactiveinvestors.co.uk/LON:XEN/Xenetic-Biosciences/rss/rns" rel="self" type="application/rss+xml" />
		<item>
			<title><![CDATA[RNS press release - Appointment of VP for Drug Development ]]></title>
			<link>http://www.proactiveinvestors.co.uk/companies/rns/120514xen2305d/</link>
			<description><![CDATA[]]></description>
			<pubDate>Mon, 14 May 2012 07:00:00 +0100</pubDate>
			<guid>http://www.proactiveinvestors.co.uk/companies/rns/120514xen2305d/</guid>
		</item>
		<item>
			<title><![CDATA[RNS press release - Senior Appointment ]]></title>
			<link>http://www.proactiveinvestors.co.uk/companies/rns/120503xen6288c/</link>
			<description><![CDATA[]]></description>
			<pubDate>Thu, 03 May 2012 07:01:00 +0100</pubDate>
			<guid>http://www.proactiveinvestors.co.uk/companies/rns/120503xen6288c/</guid>
		</item>
		<item>
			<title><![CDATA[RNS press release - Directorate Changes ]]></title>
			<link>http://www.proactiveinvestors.co.uk/companies/rns/120430xen2776c/</link>
			<description><![CDATA[]]></description>
			<pubDate>Mon, 30 Apr 2012 07:00:00 +0100</pubDate>
			<guid>http://www.proactiveinvestors.co.uk/companies/rns/120430xen2776c/</guid>
		</item>
		<item>
			<title><![CDATA[RNS press release - Amendment Holding(s) in Company ]]></title>
			<link>http://www.proactiveinvestors.co.uk/companies/rns/120320xen7230z/</link>
			<description><![CDATA[]]></description>
			<pubDate>Tue, 20 Mar 2012 15:18:00 +0000</pubDate>
			<guid>http://www.proactiveinvestors.co.uk/companies/rns/120320xen7230z/</guid>
		</item>
		<item>
			<title><![CDATA[RNS press release - Amendment Holding(s) in Company ]]></title>
			<link>http://www.proactiveinvestors.co.uk/companies/rns/120320xen7237z/</link>
			<description><![CDATA[]]></description>
			<pubDate>Tue, 20 Mar 2012 15:16:00 +0000</pubDate>
			<guid>http://www.proactiveinvestors.co.uk/companies/rns/120320xen7237z/</guid>
		</item>
		<item>
			<title><![CDATA[RNS press release - Holding(s) in Company ]]></title>
			<link>http://www.proactiveinvestors.co.uk/companies/rns/120320xen7176z/</link>
			<description><![CDATA[]]></description>
			<pubDate>Tue, 20 Mar 2012 14:25:00 +0000</pubDate>
			<guid>http://www.proactiveinvestors.co.uk/companies/rns/120320xen7176z/</guid>
		</item>
		<item>
			<title><![CDATA[RNS press release - Holding(s) in Company ]]></title>
			<link>http://www.proactiveinvestors.co.uk/companies/rns/120320xen7152z/</link>
			<description><![CDATA[]]></description>
			<pubDate>Tue, 20 Mar 2012 14:03:00 +0000</pubDate>
			<guid>http://www.proactiveinvestors.co.uk/companies/rns/120320xen7152z/</guid>
		</item>
		<item>
			<title><![CDATA[RNS press release - Holding(s) in Company ]]></title>
			<link>http://www.proactiveinvestors.co.uk/companies/rns/120320xen7186z/</link>
			<description><![CDATA[]]></description>
			<pubDate>Tue, 20 Mar 2012 14:29:00 +0000</pubDate>
			<guid>http://www.proactiveinvestors.co.uk/companies/rns/120320xen7186z/</guid>
		</item>
		<item>
			<title><![CDATA[RNS press release - Additional Listing ]]></title>
			<link>http://www.proactiveinvestors.co.uk/companies/rns/120308xen9478y/</link>
			<description><![CDATA[]]></description>
			<pubDate>Thu, 08 Mar 2012 10:00:00 +0000</pubDate>
			<guid>http://www.proactiveinvestors.co.uk/companies/rns/120308xen9478y/</guid>
		</item>
		<item>
			<title><![CDATA[RNS press release - Director/PDMR Shareholding ]]></title>
			<link>http://www.proactiveinvestors.co.uk/companies/rns/120302xen5455y/</link>
			<description><![CDATA[]]></description>
			<pubDate>Fri, 02 Mar 2012 07:00:00 +0000</pubDate>
			<guid>http://www.proactiveinvestors.co.uk/companies/rns/120302xen5455y/</guid>
		</item>
		<item>
			<title><![CDATA[RNS press release - Phase I/IIa IV trial for ErepoXen? ]]></title>
			<link>http://www.proactiveinvestors.co.uk/companies/rns/120213xen2607x/</link>
			<description><![CDATA[]]></description>
			<pubDate>Mon, 13 Feb 2012 07:00:00 +0000</pubDate>
			<guid>http://www.proactiveinvestors.co.uk/companies/rns/120213xen2607x/</guid>
		</item>
		<item>
			<title><![CDATA[RNS press release - Open Offer Update ]]></title>
			<link>http://www.proactiveinvestors.co.uk/companies/rns/120201xen5517w/</link>
			<description><![CDATA[]]></description>
			<pubDate>Wed, 01 Feb 2012 07:00:00 +0000</pubDate>
			<guid>http://www.proactiveinvestors.co.uk/companies/rns/120201xen5517w/</guid>
		</item>
		<item>
			<title><![CDATA[RNS press release - Holding(s) in Company ]]></title>
			<link>http://www.proactiveinvestors.co.uk/companies/rns/120127xen2706w/</link>
			<description><![CDATA[]]></description>
			<pubDate>Fri, 27 Jan 2012 07:00:00 +0000</pubDate>
			<guid>http://www.proactiveinvestors.co.uk/companies/rns/120127xen2706w/</guid>
		</item>
		<item>
			<title><![CDATA[RNS press release - Directorate Change ]]></title>
			<link>http://www.proactiveinvestors.co.uk/companies/rns/120127xen3098w/</link>
			<description><![CDATA[]]></description>
			<pubDate>Fri, 27 Jan 2012 11:28:00 +0000</pubDate>
			<guid>http://www.proactiveinvestors.co.uk/companies/rns/120127xen3098w/</guid>
		</item>
		<item>
			<title><![CDATA[RNS press release - Statement re. Press Comment ]]></title>
			<link>http://www.proactiveinvestors.co.uk/companies/rns/120123xen9673v/</link>
			<description><![CDATA[]]></description>
			<pubDate>Mon, 23 Jan 2012 07:02:00 +0000</pubDate>
			<guid>http://www.proactiveinvestors.co.uk/companies/rns/120123xen9673v/</guid>
		</item>
		<item>
			<title><![CDATA[RNS press release - OncoHist commences Phase I/II Trial for NHL ]]></title>
			<link>http://www.proactiveinvestors.co.uk/companies/rns/120118xen7301v/</link>
			<description><![CDATA[]]></description>
			<pubDate>Wed, 18 Jan 2012 07:00:00 +0000</pubDate>
			<guid>http://www.proactiveinvestors.co.uk/companies/rns/120118xen7301v/</guid>
		</item>
		<item>
			<title><![CDATA[RNS press release - Acquisition of SymbioTec ]]></title>
			<link>http://www.proactiveinvestors.co.uk/companies/rns/120117xen6551v/</link>
			<description><![CDATA[]]></description>
			<pubDate>Tue, 17 Jan 2012 07:00:00 +0000</pubDate>
			<guid>http://www.proactiveinvestors.co.uk/companies/rns/120117xen6551v/</guid>
		</item>
		<item>
			<title><![CDATA[RNS press release - Acquisition of SymbioTec Update ]]></title>
			<link>http://www.proactiveinvestors.co.uk/companies/rns/120104xen9426u/</link>
			<description><![CDATA[]]></description>
			<pubDate>Wed, 04 Jan 2012 07:00:00 +0000</pubDate>
			<guid>http://www.proactiveinvestors.co.uk/companies/rns/120104xen9426u/</guid>
		</item>
		<item>
			<title><![CDATA[RNS press release - Result of General Meeting ]]></title>
			<link>http://www.proactiveinvestors.co.uk/companies/rns/110901lpx4527n/</link>
			<description><![CDATA[]]></description>
			<pubDate>Thu, 01 Sep 2011 13:21:00 +0100</pubDate>
			<guid>http://www.proactiveinvestors.co.uk/companies/rns/110901lpx4527n/</guid>
		</item>
		<item>
			<title><![CDATA[RNS press release - Half Yearly Report ]]></title>
			<link>http://www.proactiveinvestors.co.uk/companies/rns/110824lpx9150m/</link>
			<description><![CDATA[]]></description>
			<pubDate>Wed, 24 Aug 2011 07:00:00 +0100</pubDate>
			<guid>http://www.proactiveinvestors.co.uk/companies/rns/110824lpx9150m/</guid>
		</item>
</channel>
</rss>

